相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Add-On Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex A Placebo-Controlled Randomized Clinical Trial
Elizabeth A. Thiele et al.
JAMA NEUROLOGY (2021)
Agitation, Oxidative Stress, and Cytokines in Alzheimer Disease: Biomarker Analyses From a Clinical Trial With Nabilone for Agitation
Myuri Ruthirakuhan et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2020)
Beyond THC and Endocannabinoids
Pal Pacher et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60 (2020)
Addiction Research Consortium: Losing and regaining control over drug intake (ReCoDe)-From trajectories to mechanisms and interventions
Andreas Heinz et al.
ADDICTION BIOLOGY (2020)
Synthetic pharmaceutical grade cannabidiol for treatment of refractory infantile spasms: A multicenter phase-2 study
Shaun A. Hussain et al.
EPILEPSY & BEHAVIOR (2020)
Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome A Randomized Clinical Trial
Ian Miller et al.
JAMA NEUROLOGY (2020)
The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial
Shlomo Almog et al.
EUROPEAN JOURNAL OF PAIN (2020)
Cannabinoid modulation of corticolimbic activation to threat in trauma-exposed adults: a preliminary study
Christine A. Rabinak et al.
PSYCHOPHARMACOLOGY (2020)
Non-Motor Symptoms in Parkinson's Disease are Reduced by Nabilone
Marina Peball et al.
ANNALS OF NEUROLOGY (2020)
Cannabinoids in the Treatment of Insomnia Disorder: A Systematic Review and Meta-Analysis
Chiranth Bhagavan et al.
CNS DRUGS (2020)
Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions
Rainer Spanagel
DIALOGUES IN CLINICAL NEUROSCIENCE (2020)
Cannabinoid Augmentation of Exposure-Based Psychotherapy for Obsessive-Compulsive Disorder
Reilly R. Kayser et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2020)
Nabilone for non-motor symptoms of Parkinson's disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study)
Marina Peball et al.
JOURNAL OF NEURAL TRANSMISSION (2019)
Higher cannabidiol plasma levels are associated with better seizure response following treatment with a pharmaceutical grade cannabidiol
Jerzy P. Szaflarski et al.
EPILEPSY & BEHAVIOR (2019)
Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial
Orrin Devinsky et al.
EPILEPSIA (2019)
Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD)
Phillip Good et al.
BMC PALLIATIVE CARE (2019)
Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis
Nicola Black et al.
LANCET PSYCHIATRY (2019)
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
Philip McGuire et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Biological correlates of self-reported new and continued abstinence in cannabis cessation treatment clinical trials
Nathaniel L. Baker et al.
DRUG AND ALCOHOL DEPENDENCE (2018)
The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration
Nicolas J. Schlienz et al.
DRUG AND ALCOHOL DEPENDENCE (2018)
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis
Peter M. Irving et al.
INFLAMMATORY BOWEL DISEASES (2018)
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
Elizabeth A. Thiele et al.
LANCET (2018)
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies
Emily Stockings et al.
PAIN (2018)
Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Delta 9-tetrahydrocannabinol in Patients With Progressive Multiple Sclerosis
Guido van Amerongen et al.
CLINICAL THERAPEUTICS (2018)
Cannabis analgesia in chronic neuropathic pain is associated with altered brain connectivity
Libat Weizman et al.
NEUROLOGY (2018)
Effects of tetrahydrocannabinol on balance and gait in patients with dementia: A randomised controlled crossover trial
Geke A. H. van den Elsen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cannabinoid Receptor Signaling in Central Regulation of Feeding Behavior: A Mini-Review
Marco Koch
FRONTIERS IN NEUROSCIENCE (2017)
A randomized-controlled trial of nabilone for the prevention of acute postoperative nausea and vomiting in elective surgery
David Neville Levin et al.
CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2017)
Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial
Mathieu Cote et al.
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2016)
Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans
Michelle R. Lofwall et al.
DRUG AND ALCOHOL DEPENDENCE (2016)
Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial
Frances R. Levin et al.
DRUG AND ALCOHOL DEPENDENCE (2016)
Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users
Evan S. Herrmann et al.
PSYCHOPHARMACOLOGY (2016)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone
Adam Bisaga et al.
DRUG AND ALCOHOL DEPENDENCE (2015)
Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy
Mark S. Wallace et al.
JOURNAL OF PAIN (2015)
Tetrahydrocannabinol for neuropsychiatric symptoms in dementia A randomized controlled trial
Geke A. H. van den Elsen et al.
NEUROLOGY (2015)
Effect of dronabinol therapy on physical activity in anorexia nervosa: a randomised, controlled trial
Alin Andries et al.
EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY (2015)
The Subjective Psychoactive Effects of Oral Dronabinol Studied in a Randomized, Controlled Crossover Clinical Trial for Pain
Mohammed A. Issa et al.
CLINICAL JOURNAL OF PAIN (2014)
Early phytocannabinoid chemistry to endocannabinoids and beyond
Raphael Mechoulam et al.
NATURE REVIEWS NEUROSCIENCE (2014)
THC reduces the anticipatory nucleus accumbens response to reward in subjects with a nicotine addiction
J. M. Jansma et al.
TRANSLATIONAL PSYCHIATRY (2013)
Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial
Luigi Alberto Pini et al.
JOURNAL OF HEADACHE AND PAIN (2012)
MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial
John Peter Zajicek et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
The cannabinoid receptor agonist delta-9-tetrahydrocannabinol does not affect visceral sensitivity to rectal distension in healthy volunteers and IBS patients
T. K. Klooker et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2011)
The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial
Mark A. Ware et al.
ANESTHESIA AND ANALGESIA (2010)
Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study
Gillinder Bedi et al.
PSYCHOPHARMACOLOGY (2010)
The Use of a Synthetic Cannabinoid in the Management of Treatment-Resistant Nightmares in Posttraumatic Stress Disorder (PTSD)
George A. Fraser
CNS NEUROSCIENCE & THERAPEUTICS (2009)
Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy
Sanjeet Narang et al.
JOURNAL OF PAIN (2008)
Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse
Margaret Haney et al.
PSYCHOPHARMACOLOGY (2008)
Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study
B. Frank et al.
BRITISH MEDICAL JOURNAL (2008)
Dronabinol and marijuana in HIV-positive marijuana smokers -: Caloric intake, mood, and sleep
Margaret Haney et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting
Eyal Meiri et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms
Alan J. Budney et al.
DRUG AND ALCOHOL DEPENDENCE (2007)
Benefits of an add-on treatment with the synthetic cannabinomimetic nabilone on patients with chronic pain -: a randomized controlled trial
Martin Pinsger et al.
WIENER KLINISCHE WOCHENSCHRIFT (2006)
Dronabinol and marijuana in HIV plus marijuana smokers: acute effects on caloric intake and mood
M Haney et al.
PSYCHOPHARMACOLOGY (2005)
Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction
DC D'Souza et al.
BIOLOGICAL PSYCHIATRY (2005)
Are oral cannabinoids safe and effective in refractory neuropathic pain?
N Attal et al.
EUROPEAN JOURNAL OF PAIN (2004)
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial
KB Svendsen et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Marijuana withdrawal in humans: Effects of oral THC or divalproex
M Haney et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Initial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 'N of 1' studies
W Notcutt et al.
ANAESTHESIA (2004)
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
J Zajicek et al.
LANCET (2003)
Short-term effects of cannabinoids in patients with HIV-1 infection - A randomized, placebo-controlled clinical trial
DI Abrams et al.
ANNALS OF INTERNAL MEDICINE (2003)
A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms
DT Wade et al.
CLINICAL REHABILITATION (2003)
Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients
BM Bredt et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Safety, tolerability, and efficacy of orally administered cannabinoids in MS
J Killestein et al.
NEUROLOGY (2002)
Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: A pilot study
KA Sieradzan et al.
NEUROLOGY (2001)
分享论文
